[Skip to Content]
[Skip to Content Landing]
Article
February 25, 1956

SALICYLAMIDE VERSUS ASPIRIN

Author Affiliations

18A Ellerdale Rd. Hampstead, N. W. 3, England.

JAMA. 1956;160(8):703. doi:10.1001/jama.1956.02960430093023

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor:—  Some physicians in the United Kingdom, who have had considerable opportunity to assess the value of salicylamide as an analgesic and antirheumatic agent in actual practice conditions, have read with great interest the article by Batterman and Grossman (J. A. M. A.159:1619 [Dec. 24] 1955), and I should like to comment and raise a question or two that appears important to us on this subject. The evaluation of the double blindfold technique is surely a subject for discussion on its own merits, and one would not presume to criticize the team of the department of medicine of New York Medical College, and only two points in connection with that part of the thesis are controversial. 1. If it is accepted that much rheumatism is of psychogenic origin, a satisfactory evaluation of benefit by any technique is liable to error because of the notorious difficulty in

First Page Preview View Large
First page PDF preview
First page PDF preview
×